Three Antihypertensives in a Single Pill after Intracerebral Hemorrhage (TRIDENT) @NEJMgroup

Uploaded April 2026 | Updated September 2026, 1 week ago

Among survivors of intracerebral hemorrhage, a single pill with three low-dose antihypertensive agents added to standard care was associated with a lower incidence of stroke and major cardiovascular events than placebo.

Read the full TRIDENT trial results and Research Summary at NEJM.org.

#neurology #clinicaltrials #nejm

Three Antihypertensives in a Single Pill after Intracerebral Hemorrhage (TRIDENT)

60-Second Journal Club: Risk of Pediatric & Adolescent Cancer Associated w/ Medical Imaging (RIC)

Perspective Video Interview: Managing Uncertainty

Three newsworthy items from NEJM in June

Images in Clinical Medicine: Erythema Multiforme

Evaluating Value-Based Care: A Look Inside Risant Health’s Platform Strategy

Cardiovascular Risk Factors — Hypertension | NEJM

60-Second Journal Club: Randomized Trial of Sedative Choice for Intubation

$Ask the Expert: Why Do HFpEF Patients Experience Shortness of Breath? Neha J. Pagidipati, MD, and Donald Lloyd-Jones, MD, discuss common symptoms of heart failure with preserved ejection fraction (HFpEF) and why they occur. Watch “HFpEF Explained — Living with HFpEF,” part three in a three-part Double Take video miniseries, now available on our YouTube channel.$